Reports


Global Chemotherapy Induced Peripheral Neuropathy Treatment Market and Forecast 2020-2026

  • TBI288495
  • October 07, 2020
  • Global
  • 132 pages
  • IFF Market Research
                                              CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.

There are no approved therapies to combat the debilitating symptoms of CIPN now. Current alternatives include Palliative care using antidepressants, antiepileptic drugs, or opioids, all of which have well known adverse side effects.

By region, the United States has the highest share of income, reaching 47.25 percent in 2019.

Market Analysis and Insights: Global Chemotherapy Induced Peripheral Neuropathy Treatment Market
The research report studies the Chemotherapy Induced Peripheral Neuropathy Treatment market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

The global Chemotherapy Induced Peripheral Neuropathy Treatment market size is projected to reach US$ 2276.6 million by 2026, from US$ 1572.6 million in 2020, at a CAGR of 6.4% during 2021-2026.
Global Chemotherapy Induced Peripheral Neuropathy Treatment Scope and Segment

The global Chemotherapy Induced Peripheral Neuropathy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Peripheral Neuropathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by

Application for the period 2015-2026.

by Type, the market is primarily split into
  • Calcium Channel Alpha2-delta Ligands
  • Antidepressants
  • Opioids
  • Others
by Application, this report covers the following segments
  • Platinum Agents
  • Taxanes
  • Vinca Alkaloids
  • Others
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market. The Chemotherapy Induced Peripheral Neuropathy Treatment key players in this market include:
  • Aptinyx Inc
  • Asahi Kasei Pharma Corp
  • Regenacy Pharmaceuticals
  • MAKScientific LLC
  • Metys Pharmaceuticals AG
  • Nemus Bioscience Inc
  • PledPharma
  • Sova Pharmaceuticals Inc
  • DermaXon LLC
  • Kineta Inc
  • Krenitsky Pharmaceuticals Inc
  • PeriphaGen
  • Apexian Pharma
  • WinSanTor
  • Solasia Pharma K.K.

Table of Contents

Chapter 1. Preface
	
		1.1. Report Description
		
			1.1.1. Objective
			1.1.2. Target Audience
			1.1.3. Unique Selling Proposition (USP) & Offerings
		
		
		1.2. Research Scope
		1.3. Research Methodology
		
			1.3.1. Market Research Process
			1.3.2. Market Research Methodology
			1.3.3. Level 1: Primary Research
			1.3.4. Level 2: Secondary Research
			1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
			
Chapter 2. Executive Summary
	
		2.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment 2019-2029 (USD Billion)
		2.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment: Market Snapshot
	 
Chapter 3. Global Chemotherapy Induced Peripheral Neuropathy Treatment - Industry Analysis
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form

 

Related Reports